Primary markers—FKBP5 and CLDN4 carry the headline: FKBP5 reports on the HP-engaged steroid/PPAR axis in adjacent tissue, while CLDN4 reports on tumor epithelial remodeling that underlies invasion. The gene discussed is CLDN4; the disease is neoplasm.